- Home
- RGLS vs ICUCW Comparison
RGLS vs ICUCW Comparison
Compare RGLS & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- ICUCW
- Stock Information
- Founded
- RGLS 2007
- ICUCW N/A
- Country
- RGLS United States
- ICUCW United States
- Employees
- RGLS N/A
- ICUCW 19
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- RGLS Health Care
- ICUCW Health Care
- Exchange
- RGLS Nasdaq
- ICUCW Nasdaq
- Market Cap
- RGLS N/A
- ICUCW N/A
- IPO Year
- RGLS 2012
- ICUCW 2021
- Fundamental
- Price
- RGLS $7.88
- ICUCW $0.02
- Analyst Decision
- RGLS Buy
- ICUCW
- Analyst Count
- RGLS 6
- ICUCW 0
- Target Price
- RGLS $8.50
- ICUCW N/A
- AVG Volume (30 Days)
- RGLS 2.0M
- ICUCW N/A
- Earning Date
- RGLS 08-07-2025
- ICUCW N/A
- Dividend Yield
- RGLS N/A
- ICUCW N/A
- EPS Growth
- RGLS N/A
- ICUCW N/A
- EPS
- RGLS N/A
- ICUCW N/A
- Revenue
- RGLS N/A
- ICUCW N/A
- Revenue This Year
- RGLS N/A
- ICUCW N/A
- Revenue Next Year
- RGLS N/A
- ICUCW N/A
- P/E Ratio
- RGLS N/A
- ICUCW N/A
- Revenue Growth
- RGLS N/A
- ICUCW N/A
- 52 Week Low
- RGLS $0.83
- ICUCW N/A
- 52 Week High
- RGLS $8.35
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- RGLS 59.29
- ICUCW N/A
- Support Level
- RGLS $8.03
- ICUCW N/A
- Resistance Level
- RGLS $8.29
- ICUCW N/A
- Average True Range (ATR)
- RGLS 0.14
- ICUCW 0.00
- MACD
- RGLS -0.15
- ICUCW 0.00
- Stochastic Oscillator
- RGLS 18.97
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.